Batch-to-batch variability in compounded peptides is a documented concern
Visual Format: Approved vs investigational status map Key Labels: Cosmetic product, compounded peptide, non-injectable route, injectable route, FDA safety concern, approved drug label, regulatory standards, product category Suggested Layout: Use a horizontal status map with four blocks: Cosmetic context, Non-injectable compounding review, Injectable safety concern, and Approved drug labeling. Add a note that product category changes evidence and safety interpretation
NSAIDs, joint supplements, physical therapy and maybe, if youve been doing a lot of research, youve landed on something called BPC-157
What PCAC Review Does Not Mean This is where a lot of peptide content gets sloppy
Unfortunately, in the presence of disease, environmental exposures and genetics, our bodys ability to make this critical compound diminishes greatly